

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glyoxylate metabolic process (GO:0046487) | 5.26950302 |
| 2 | regulation of protein activation cascade (GO:2000257) | 5.22131880 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 5.20865102 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 5.12795677 |
| 5 | regulation of fibrinolysis (GO:0051917) | 5.10455935 |
| 6 | regulation of cholesterol esterification (GO:0010872) | 5.08217999 |
| 7 | cellular glucuronidation (GO:0052695) | 4.93757319 |
| 8 | protein carboxylation (GO:0018214) | 4.92080787 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.92080787 |
| 10 | complement activation, alternative pathway (GO:0006957) | 4.91619618 |
| 11 | uronic acid metabolic process (GO:0006063) | 4.89003202 |
| 12 | glucuronate metabolic process (GO:0019585) | 4.89003202 |
| 13 | regulation of complement activation (GO:0030449) | 4.84437427 |
| 14 | drug catabolic process (GO:0042737) | 4.77328594 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.71297267 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 4.71297267 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.62124090 |
| 18 | negative regulation of sterol transport (GO:0032372) | 4.61082790 |
| 19 | negative regulation of cholesterol transport (GO:0032375) | 4.61082790 |
| 20 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.49243903 |
| 21 | protein-lipid complex remodeling (GO:0034368) | 4.44936625 |
| 22 | macromolecular complex remodeling (GO:0034367) | 4.44936625 |
| 23 | plasma lipoprotein particle remodeling (GO:0034369) | 4.44936625 |
| 24 | cholesterol efflux (GO:0033344) | 4.40937755 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.37848974 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 4.37848974 |
| 27 | regulation of bile acid biosynthetic process (GO:0070857) | 4.33080654 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 4.31072996 |
| 29 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.30880544 |
| 30 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.30880544 |
| 31 | phospholipid efflux (GO:0033700) | 4.30685221 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.29029946 |
| 33 | plasma lipoprotein particle assembly (GO:0034377) | 4.25448617 |
| 34 | bile acid metabolic process (GO:0008206) | 4.16450489 |
| 35 | aromatic amino acid family catabolic process (GO:0009074) | 4.14210595 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 4.11420934 |
| 37 | exogenous drug catabolic process (GO:0042738) | 4.09962905 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.07497125 |
| 39 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03983397 |
| 40 | drug metabolic process (GO:0017144) | 4.02875849 |
| 41 | bile acid and bile salt transport (GO:0015721) | 4.01134717 |
| 42 | bile acid biosynthetic process (GO:0006699) | 3.99901833 |
| 43 | acylglycerol homeostasis (GO:0055090) | 3.92974434 |
| 44 | triglyceride homeostasis (GO:0070328) | 3.92974434 |
| 45 | urea metabolic process (GO:0019627) | 3.88994439 |
| 46 | fibrinolysis (GO:0042730) | 3.86921670 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 3.86897191 |
| 48 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86636129 |
| 49 | nitrogen cycle metabolic process (GO:0071941) | 3.84768194 |
| 50 | reverse cholesterol transport (GO:0043691) | 3.84197427 |
| 51 | intestinal cholesterol absorption (GO:0030299) | 3.82036445 |
| 52 | acute-phase response (GO:0006953) | 3.73542703 |
| 53 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.73063367 |
| 54 | plasma lipoprotein particle organization (GO:0071827) | 3.69658244 |
| 55 | protein-lipid complex assembly (GO:0065005) | 3.69435086 |
| 56 | flavonoid metabolic process (GO:0009812) | 3.65786172 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 3.63466885 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 3.63466885 |
| 59 | tryptophan catabolic process (GO:0006569) | 3.63466885 |
| 60 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.60878803 |
| 61 | urea cycle (GO:0000050) | 3.56597789 |
| 62 | negative regulation of blood coagulation (GO:0030195) | 3.56138536 |
| 63 | negative regulation of hemostasis (GO:1900047) | 3.56138536 |
| 64 | intestinal absorption (GO:0050892) | 3.55781856 |
| 65 | alkaloid metabolic process (GO:0009820) | 3.52986227 |
| 66 | ethanol oxidation (GO:0006069) | 3.51722203 |
| 67 | protein-lipid complex subunit organization (GO:0071825) | 3.42486644 |
| 68 | vitamin biosynthetic process (GO:0009110) | 3.40837947 |
| 69 | arginine metabolic process (GO:0006525) | 3.40763903 |
| 70 | negative regulation of protein activation cascade (GO:2000258) | 3.40344984 |
| 71 | omega-hydroxylase P450 pathway (GO:0097267) | 3.40123182 |
| 72 | heme transport (GO:0015886) | 3.35978723 |
| 73 | cholesterol homeostasis (GO:0042632) | 3.33676732 |
| 74 | negative regulation of coagulation (GO:0050819) | 3.31038758 |
| 75 | protein activation cascade (GO:0072376) | 3.29385383 |
| 76 | serine family amino acid catabolic process (GO:0009071) | 3.27766165 |
| 77 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.27498347 |
| 78 | sterol homeostasis (GO:0055092) | 3.26821984 |
| 79 | drug transmembrane transport (GO:0006855) | 3.26525517 |
| 80 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.25274856 |
| 81 | L-ascorbic acid metabolic process (GO:0019852) | 3.20862781 |
| 82 | oxidative demethylation (GO:0070989) | 3.19008691 |
| 83 | negative regulation of wound healing (GO:0061045) | 3.15427319 |
| 84 | steroid catabolic process (GO:0006706) | 3.15254562 |
| 85 | regulation of humoral immune response (GO:0002920) | 3.15047605 |
| 86 | lipoprotein metabolic process (GO:0042157) | 3.11162724 |
| 87 | vitamin D metabolic process (GO:0042359) | 3.02845666 |
| 88 | ethanol metabolic process (GO:0006067) | 3.02246024 |
| 89 | complement activation (GO:0006956) | 3.02222101 |
| 90 | angiotensin maturation (GO:0002003) | 3.02164987 |
| 91 | negative regulation of complement activation (GO:0045916) | 3.02076228 |
| 92 | acute inflammatory response (GO:0002526) | 3.00608846 |
| 93 | sulfur amino acid catabolic process (GO:0000098) | 3.00151734 |
| 94 | regulation of apoptotic cell clearance (GO:2000425) | 2.99763251 |
| 95 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.99747717 |
| 96 | complement activation, classical pathway (GO:0006958) | 2.98194716 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 2.97701879 |
| 98 | amine catabolic process (GO:0009310) | 2.97701879 |
| 99 | drug transport (GO:0015893) | 2.92463869 |
| 100 | tryptophan metabolic process (GO:0006568) | 2.90596640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.50480105 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.63167210 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.46893513 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.78807790 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70974591 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.10070760 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.08642040 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.00285015 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94742556 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.73160269 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.71356693 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.38814504 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.35370868 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.30431756 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.25671875 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.07482941 |
| 17 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.98432027 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.92238338 |
| 19 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.84349730 |
| 20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.74450309 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.66504576 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62142120 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.55433275 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.54446328 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.52947214 |
| 26 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41908925 |
| 27 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37013829 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36646534 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26700758 |
| 30 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.25842288 |
| 31 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.22142302 |
| 32 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.21528232 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21442048 |
| 34 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.19362696 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.18935814 |
| 36 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18468926 |
| 37 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.18232885 |
| 38 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17743877 |
| 39 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.17313736 |
| 40 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08061247 |
| 41 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06522406 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.05322890 |
| 43 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.05122817 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.04381664 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03993552 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03593847 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03218378 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02437342 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01680015 |
| 50 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.01254562 |
| 51 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.00959297 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00236969 |
| 53 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97161040 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96865208 |
| 55 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96404777 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95937474 |
| 57 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95937474 |
| 58 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95802669 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95725947 |
| 60 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.93699879 |
| 61 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93656079 |
| 62 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93656079 |
| 63 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.90940336 |
| 64 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.90346017 |
| 65 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90242954 |
| 66 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89169421 |
| 67 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88339709 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.87270302 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87148786 |
| 70 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.86981575 |
| 71 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.86698559 |
| 72 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86439922 |
| 73 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.85816315 |
| 74 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.85657168 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.85547128 |
| 76 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84947090 |
| 77 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84889680 |
| 78 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.84621797 |
| 79 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84499088 |
| 80 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.83561627 |
| 81 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.83534055 |
| 82 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.82204010 |
| 83 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.81713438 |
| 84 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.80765962 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80588103 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.80113177 |
| 87 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.79925181 |
| 88 | NCOR_22424771_ChIP-Seq_293T_Human | 0.79729234 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79558020 |
| 90 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.79089197 |
| 91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.79050297 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.78915284 |
| 93 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.78880714 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78636975 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78332998 |
| 96 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.78129523 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.77558238 |
| 98 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77132992 |
| 99 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.76533012 |
| 100 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.76440863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.86372183 |
| 2 | MP0005360_urolithiasis | 5.46601608 |
| 3 | MP0005365_abnormal_bile_salt | 5.19304135 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.83172149 |
| 5 | MP0003195_calcinosis | 4.61567313 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.14160203 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.48068130 |
| 8 | MP0009840_abnormal_foam_cell | 3.42026540 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.17245973 |
| 10 | MP0003868_abnormal_feces_composition | 2.95363369 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.76280098 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.72418448 |
| 13 | MP0003252_abnormal_bile_duct | 2.48760114 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.37063467 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.29044264 |
| 16 | MP0001764_abnormal_homeostasis | 2.00479667 |
| 17 | MP0005058_abnormal_lysosome_morphology | 1.91725759 |
| 18 | MP0005332_abnormal_amino_acid | 1.86342125 |
| 19 | MP0003303_peritoneal_inflammation | 1.77790357 |
| 20 | MP0009697_abnormal_copulation | 1.72960029 |
| 21 | MP0009785_altered_susceptibility_to | 1.67855376 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.57283154 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.54062971 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 1.53641399 |
| 25 | MP0000609_abnormal_liver_physiology | 1.51889511 |
| 26 | MP0006082_CNS_inflammation | 1.51193325 |
| 27 | MP0000604_amyloidosis | 1.49951292 |
| 28 | MP0009764_decreased_sensitivity_to | 1.40718354 |
| 29 | MP0005636_abnormal_mineral_homeostasis | 1.36680067 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.31826709 |
| 31 | MP0008469_abnormal_protein_level | 1.28748285 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.24850396 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.20165428 |
| 34 | MP0010386_abnormal_urinary_bladder | 1.18614519 |
| 35 | MP0005408_hypopigmentation | 1.18462777 |
| 36 | MP0004043_abnormal_pH_regulation | 1.16379913 |
| 37 | MP0003075_altered_response_to | 1.11581669 |
| 38 | MP0001790_abnormal_immune_system | 1.10631855 |
| 39 | MP0005387_immune_system_phenotype | 1.10631855 |
| 40 | MP0003436_decreased_susceptibility_to | 1.09553733 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.08811199 |
| 42 | MP0003186_abnormal_redox_activity | 1.04713476 |
| 43 | MP0002254_reproductive_system_inflammat | 1.01868703 |
| 44 | MP0001845_abnormal_inflammatory_respons | 1.01766082 |
| 45 | MP0003172_abnormal_lysosome_physiology | 0.99000737 |
| 46 | MP0005025_abnormal_response_to | 0.95210115 |
| 47 | MP0002837_dystrophic_cardiac_calcinosis | 0.93792045 |
| 48 | MP0001835_abnormal_antigen_presentation | 0.93419565 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 0.91020105 |
| 50 | MP0000566_synostosis | 0.89561878 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89271600 |
| 52 | MP0003724_increased_susceptibility_to | 0.83451428 |
| 53 | MP0009642_abnormal_blood_homeostasis | 0.82845863 |
| 54 | MP0001501_abnormal_sleep_pattern | 0.82410435 |
| 55 | MP0001533_abnormal_skeleton_physiology | 0.79306946 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 0.78114953 |
| 57 | MP0005166_decreased_susceptibility_to | 0.77994745 |
| 58 | MP0002419_abnormal_innate_immunity | 0.77566668 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.76753784 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 0.76569605 |
| 61 | MP0005376_homeostasis/metabolism_phenot | 0.76207997 |
| 62 | MP0001756_abnormal_urination | 0.75343107 |
| 63 | MP0001663_abnormal_digestive_system | 0.73455897 |
| 64 | MP0005671_abnormal_response_to | 0.73346703 |
| 65 | MP0005451_abnormal_body_composition | 0.73270225 |
| 66 | MP0004510_myositis | 0.73196707 |
| 67 | MP0002136_abnormal_kidney_physiology | 0.70269740 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 0.67814093 |
| 69 | MP0005000_abnormal_immune_tolerance | 0.67704954 |
| 70 | MP0008872_abnormal_physiological_respon | 0.67593285 |
| 71 | MP0005448_abnormal_energy_balance | 0.67362404 |
| 72 | MP0009763_increased_sensitivity_to | 0.66511978 |
| 73 | MP0006054_spinal_hemorrhage | 0.65381218 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.65276767 |
| 75 | MP0003646_muscle_fatigue | 0.64988920 |
| 76 | MP0003879_abnormal_hair_cell | 0.64786966 |
| 77 | MP0000343_altered_response_to | 0.64516403 |
| 78 | MP0003690_abnormal_glial_cell | 0.64160224 |
| 79 | MP0005535_abnormal_body_temperature | 0.61065055 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.60976456 |
| 81 | MP0005647_abnormal_sex_gland | 0.60848398 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.59580242 |
| 83 | MP0005164_abnormal_response_to | 0.59337427 |
| 84 | MP0002090_abnormal_vision | 0.59171396 |
| 85 | MP0003300_gastrointestinal_ulcer | 0.59023238 |
| 86 | MP0000598_abnormal_liver_morphology | 0.58978260 |
| 87 | MP0005464_abnormal_platelet_physiology | 0.58444874 |
| 88 | MP0002078_abnormal_glucose_homeostasis | 0.58401717 |
| 89 | MP0001800_abnormal_humoral_immune | 0.57438980 |
| 90 | MP0003011_delayed_dark_adaptation | 0.57161772 |
| 91 | MP0002723_abnormal_immune_serum | 0.56329611 |
| 92 | MP0005310_abnormal_salivary_gland | 0.56300146 |
| 93 | MP0000685_abnormal_immune_system | 0.55685386 |
| 94 | MP0001853_heart_inflammation | 0.54007844 |
| 95 | MP0000249_abnormal_blood_vessel | 0.53888254 |
| 96 | MP0005187_abnormal_penis_morphology | 0.53414100 |
| 97 | MP0001324_abnormal_eye_pigmentation | 0.51160892 |
| 98 | MP0001986_abnormal_taste_sensitivity | 0.50287894 |
| 99 | MP0001873_stomach_inflammation | 0.49764437 |
| 100 | MP0003122_maternal_imprinting | 0.49233167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.25745520 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.29016782 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.82477404 |
| 4 | Complement deficiency (HP:0004431) | 5.74011148 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.50964138 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.49544487 |
| 7 | Glomerulonephritis (HP:0000099) | 5.32813123 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.56822121 |
| 9 | Xanthomatosis (HP:0000991) | 4.43867944 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.23681061 |
| 11 | Abnormality of complement system (HP:0005339) | 4.11253220 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.03254560 |
| 13 | Joint hemorrhage (HP:0005261) | 3.89016868 |
| 14 | Generalized aminoaciduria (HP:0002909) | 3.73398068 |
| 15 | Fat malabsorption (HP:0002630) | 3.36366766 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.26770084 |
| 17 | Conjugated hyperbilirubinemia (HP:0002908) | 3.26086790 |
| 18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.23533665 |
| 19 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.23533665 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21801553 |
| 21 | Vacuolated lymphocytes (HP:0001922) | 3.20770387 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10181508 |
| 23 | Nephritis (HP:0000123) | 3.06090700 |
| 24 | Epidermoid cyst (HP:0200040) | 2.95425496 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 2.95226304 |
| 26 | Abnormality of proline metabolism (HP:0010907) | 2.81770813 |
| 27 | Hydroxyprolinuria (HP:0003080) | 2.81770813 |
| 28 | Metaphyseal irregularity (HP:0003025) | 2.73093075 |
| 29 | Abnormal ciliary motility (HP:0012262) | 2.72168573 |
| 30 | Glycosuria (HP:0003076) | 2.70781871 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 2.70781871 |
| 32 | Hyperammonemia (HP:0001987) | 2.66224552 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65683628 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.64664474 |
| 35 | Purpura (HP:0000979) | 2.62197263 |
| 36 | Abnormal pupillary function (HP:0007686) | 2.62122250 |
| 37 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60504563 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.58721720 |
| 39 | Widely patent fontanelles and sutures (HP:0004492) | 2.55202693 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53458690 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53458690 |
| 42 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53458690 |
| 43 | Malnutrition (HP:0004395) | 2.52746721 |
| 44 | Spontaneous abortion (HP:0005268) | 2.48024345 |
| 45 | Increased serum ferritin (HP:0003281) | 2.46513114 |
| 46 | Steatorrhea (HP:0002570) | 2.44324494 |
| 47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43264371 |
| 48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43264371 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43264371 |
| 50 | Rickets (HP:0002748) | 2.40470748 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.39871399 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.39871399 |
| 53 | Hyperglycinemia (HP:0002154) | 2.39188361 |
| 54 | Alkalosis (HP:0001948) | 2.34406972 |
| 55 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.33963352 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.32371538 |
| 57 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.31314995 |
| 58 | Nausea (HP:0002018) | 2.29418009 |
| 59 | Hemorrhage of the eye (HP:0011885) | 2.28429581 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.22934135 |
| 61 | Abnormality of iron homeostasis (HP:0011031) | 2.22823753 |
| 62 | Hyperglycinuria (HP:0003108) | 2.22727450 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21444085 |
| 64 | Abnormality of glycine metabolism (HP:0010895) | 2.21444085 |
| 65 | Rhinitis (HP:0012384) | 2.21211584 |
| 66 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13018189 |
| 67 | Vascular calcification (HP:0004934) | 2.12828472 |
| 68 | Pulmonary embolism (HP:0002204) | 2.12437603 |
| 69 | Metabolic acidosis (HP:0001942) | 2.10322614 |
| 70 | Gangrene (HP:0100758) | 2.09883452 |
| 71 | Hypercholesterolemia (HP:0003124) | 2.08075995 |
| 72 | Acanthocytosis (HP:0001927) | 2.07103542 |
| 73 | Stomatitis (HP:0010280) | 2.06815783 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 2.06527954 |
| 75 | Irritability (HP:0000737) | 2.06421313 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00863011 |
| 77 | Pancreatitis (HP:0001733) | 2.00815153 |
| 78 | Gingival bleeding (HP:0000225) | 1.99743750 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 1.99561405 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 1.99240729 |
| 81 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.97439774 |
| 82 | Absent/shortened dynein arms (HP:0200106) | 1.97439774 |
| 83 | Hyperactive renin-angiotensin system (HP:0000841) | 1.94607241 |
| 84 | Retinal atrophy (HP:0001105) | 1.90186470 |
| 85 | Retrobulbar optic neuritis (HP:0100654) | 1.89930103 |
| 86 | Optic neuritis (HP:0100653) | 1.89930103 |
| 87 | Potter facies (HP:0002009) | 1.89306605 |
| 88 | Facial shape deformation (HP:0011334) | 1.89306605 |
| 89 | Abnormal urine phosphate concentration (HP:0012599) | 1.83781629 |
| 90 | Osteomalacia (HP:0002749) | 1.82112692 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 1.81136087 |
| 92 | Orchitis (HP:0100796) | 1.80284368 |
| 93 | Lethargy (HP:0001254) | 1.78341901 |
| 94 | Chronic sinusitis (HP:0011109) | 1.78118404 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 1.74384494 |
| 96 | Hypoalphalipoproteinemia (HP:0003233) | 1.70726702 |
| 97 | Hypophosphatemia (HP:0002148) | 1.70682682 |
| 98 | Joint swelling (HP:0001386) | 1.69009385 |
| 99 | Skin nodule (HP:0200036) | 1.68786135 |
| 100 | Mesangial abnormality (HP:0001966) | 1.68671461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.52778009 |
| 2 | ADRBK2 | 3.40938094 |
| 3 | IRAK3 | 3.34768954 |
| 4 | NME2 | 2.53363128 |
| 5 | MAP3K12 | 2.52018593 |
| 6 | FRK | 2.46008516 |
| 7 | MATK | 2.28497281 |
| 8 | FGFR4 | 2.24789540 |
| 9 | GRK7 | 2.21198304 |
| 10 | DDR2 | 2.20632641 |
| 11 | WNK4 | 2.08545242 |
| 12 | TBK1 | 1.80884372 |
| 13 | STK39 | 1.80219387 |
| 14 | MAP3K11 | 1.79827863 |
| 15 | IRAK1 | 1.78152646 |
| 16 | PIK3CA | 1.71934235 |
| 17 | FGFR3 | 1.70961784 |
| 18 | GRK1 | 1.68943562 |
| 19 | WNK3 | 1.66530801 |
| 20 | IRAK4 | 1.64258222 |
| 21 | MAPK15 | 1.55907372 |
| 22 | MAP3K3 | 1.52324990 |
| 23 | IKBKB | 1.51683211 |
| 24 | MST4 | 1.49545807 |
| 25 | CASK | 1.48933018 |
| 26 | TAOK1 | 1.44350501 |
| 27 | ABL2 | 1.43649842 |
| 28 | MAP3K14 | 1.43206635 |
| 29 | MAP2K2 | 1.37975801 |
| 30 | MAP3K4 | 1.37683792 |
| 31 | TNIK | 1.28207199 |
| 32 | NEK9 | 1.25405155 |
| 33 | TXK | 1.23443188 |
| 34 | DAPK2 | 1.21467622 |
| 35 | INSRR | 1.20930477 |
| 36 | MAP2K6 | 1.20045871 |
| 37 | TGFBR2 | 1.19953872 |
| 38 | OXSR1 | 1.18090285 |
| 39 | TYK2 | 1.16563150 |
| 40 | IKBKE | 1.15691783 |
| 41 | PINK1 | 1.12307311 |
| 42 | MAP4K2 | 1.12240620 |
| 43 | CSK | 1.12194187 |
| 44 | MUSK | 1.11823665 |
| 45 | TYRO3 | 1.07922491 |
| 46 | PRKAA2 | 1.01394612 |
| 47 | NLK | 1.00532666 |
| 48 | ERN1 | 0.98525909 |
| 49 | CHUK | 0.97191527 |
| 50 | MAP3K1 | 0.94129784 |
| 51 | STK38L | 0.93729840 |
| 52 | MAP3K2 | 0.93088962 |
| 53 | EPHA3 | 0.92908942 |
| 54 | MST1R | 0.92417067 |
| 55 | RIPK1 | 0.92213983 |
| 56 | FGR | 0.90283881 |
| 57 | PRKCG | 0.89205257 |
| 58 | BMPR1B | 0.87754810 |
| 59 | PIM2 | 0.87579443 |
| 60 | CDC42BPA | 0.86731496 |
| 61 | STK16 | 0.84658405 |
| 62 | BCKDK | 0.80771631 |
| 63 | PRKACG | 0.80721165 |
| 64 | STK24 | 0.79248398 |
| 65 | PIK3CG | 0.76648970 |
| 66 | MAP3K5 | 0.76396838 |
| 67 | EPHA2 | 0.69740736 |
| 68 | FGFR2 | 0.68555796 |
| 69 | TAOK2 | 0.67501089 |
| 70 | LYN | 0.67214141 |
| 71 | TLK1 | 0.65156633 |
| 72 | MARK3 | 0.64638467 |
| 73 | PRKG2 | 0.64550662 |
| 74 | EPHB2 | 0.64471626 |
| 75 | PRKCI | 0.63848988 |
| 76 | PRKCZ | 0.57874412 |
| 77 | TNK2 | 0.56628622 |
| 78 | TIE1 | 0.56381819 |
| 79 | PRKCA | 0.55183118 |
| 80 | DYRK1B | 0.52376999 |
| 81 | SGK1 | 0.50883613 |
| 82 | PAK3 | 0.50635189 |
| 83 | FER | 0.50326552 |
| 84 | MAPK11 | 0.48970424 |
| 85 | PRKACA | 0.48757791 |
| 86 | PRKCQ | 0.47508398 |
| 87 | ERBB2 | 0.46806491 |
| 88 | PRKCE | 0.46165058 |
| 89 | PRKG1 | 0.45897664 |
| 90 | TAOK3 | 0.45165190 |
| 91 | LCK | 0.39563799 |
| 92 | IGF1R | 0.38830172 |
| 93 | MAP4K1 | 0.38751780 |
| 94 | IRAK2 | 0.37675632 |
| 95 | LMTK2 | 0.37506057 |
| 96 | ABL1 | 0.36468118 |
| 97 | MAP2K1 | 0.36083203 |
| 98 | NEK1 | 0.35052821 |
| 99 | PDPK1 | 0.30344824 |
| 100 | MAP2K4 | 0.29286739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.42406459 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.35535000 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31572839 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.83860148 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.81713898 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.68250527 |
| 7 | Retinol metabolism_Homo sapiens_hsa00830 | 2.61054317 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.59521217 |
| 9 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.54372565 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.35518717 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.30921171 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.24607090 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12919757 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.09170908 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99385745 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92206584 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.91159099 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.91004092 |
| 19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.90652036 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88235853 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.87667624 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.84731007 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81697923 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.81675233 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.73362191 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.71760677 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68008263 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.61693897 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60006424 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.56860122 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37262077 |
| 32 | Mineral absorption_Homo sapiens_hsa04978 | 1.33981838 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.29250979 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26732619 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26606271 |
| 36 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.21441307 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17823761 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.14135177 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07661611 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07548748 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05132762 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03151889 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01290357 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.00088580 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.00045841 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98336025 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90597900 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89840962 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88854362 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.87240634 |
| 51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86748915 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 0.86293526 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81963939 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.81432936 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80136746 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78401465 |
| 57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77138991 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.75815747 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 0.75248841 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75180833 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.73500192 |
| 62 | Lysosome_Homo sapiens_hsa04142 | 0.73241202 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73240610 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67865767 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67472195 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65522177 |
| 67 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64840267 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.60269524 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59807441 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59574581 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.59273404 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59172942 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58628585 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58138384 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55159813 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52219225 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49383410 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48989897 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48213288 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46882655 |
| 81 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41167383 |
| 82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38598762 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38273225 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.34380636 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33553091 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 0.32342910 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32207527 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28248096 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27881135 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27870968 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.26389563 |
| 92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26157033 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25567843 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.24760635 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24170345 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23286910 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.21965936 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21094944 |
| 99 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20114322 |
| 100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.19116193 |

